Helicobacter pylori can persistently colonize the mucosa of the human stomach, resulting in gastric disorders. Endoscopic biopsy for rapid urease test and histopathologic examination are considered as the most accurate diagnostic methods for H. pylori infection. Serological methods are recommended for children because of invasiveness of the diagnosis mentioned above. Here, the cytotoxin-associated gene A protein (Cag A), as an immunodominant antigen, was subdivided to determine which regions harbor antigenicity for humans. CagA was divided into 17 overlapping fragments of ∼400 bp, which were used for the analysis of antigenic determinants. The partial proteins were subjected to immunoblot analysis using pooled serum samples from children with gastric symptoms. A partial recombinant CagA protein containing epitope regions (683-749 amino acids), which were identified in this study, was produced and used for the detection of anti-CagA antibodies and further investigated its serodiagnostic value for determination of H. pylori infection in children. The serum IgG reactivities from children with gastric symptoms were significantly three times more than that of serum samples from children with non-gastric symptoms (P < 0.005). Moreover, the serum IgG reactivities from children showing strong urease activity of gastric biopsies were significantly higher than those with moderate and weak urease activities (P < 0.05). Hence, the partial CagA is a candidate antigen for diagnosis of H. pylori infection.
INTRODUCTION
Helicobacter pylori has been known as a causative agent of human chronic gastritis, since it was first isolated from a patient with gastritis in 1982 (Marshall and Warren 1984; Hatakeyama 2014) . The prevalence of H. pylori infection varies geographically, but about half of the world's population is estimated to be infected with H. pylori (Jones, Whitmire and Merrell 2010; Hatakeyama 2014) . Peptic ulcer disease, 75% of gastric ulcers and 90% of duodenal ulcers are attributed to H. pylori infection, and two distinct types of mucosa-associated lymphoid tissue lymphoma and adenocarcinoma are also considered to be associated with H. pylori infection (Parsonnet et al. 1991 (Parsonnet et al. , 1994 Ernst and Gold 2000; Jones, Whitmire and Merrell 2010) . Therefore, H. pylori is the only bacterium classified as a class I carcinogen by the World Health Organization (IARC 1994; Jones, Whitmire and Merrell 2010) .
Helicobacter pylori infection has shown a declining trend worldwide because socioeconomic conditions have rapidly improved in developed countries (Salih 2009 ). However, H. pylori infection is still prevalent in developing countries, where it shows high infection rates (Salih 2009 ). In particular, a prevalence of 2.4%-13.6% was reported for children aged <3 years in developed countries, such as Japan, Germany, Ireland and Sweden; in contrast, prevalence rates of 22.6%-80% were reported in children from Vietnam, Saudi Arabia, Egypt, Brazil, Mexico, India and Bangladesh (Salih 2009 ). Helicobacter pylori is known to usually infect during early childhood and is difficult to eradicate (Jang et al. 2015) . Most infected children are asymptomatic; however, some show gastrointestinal symptoms, and some patients with non-gastric diseases, such as iron-deficiency anemia and epilepsy, also show potential associations with H. pylori (Barabino et al. 1999; Okuda et al. 2004; de Angelis et al. 2007; Ozturk et al. 2007; Akada et al. 2014 ). Although the role of H. pylori in the cause of gastrointestinal symptoms has been controversial, including recurrent abdominal pains in children, many reports have suggested an association between H. pylori infection and abdominal pains (Spee et al. 2010; Jang et al. 2015) .
Until now, endoscopic biopsy, culture, rapid urease tests (CLO test), 13 C-or 14 C-urea breath tests ( 13 C-UBT or 14 C-UBT), urine antibody, serum antibody and stool antigen tests have been reported as the methods available for the diagnosis of H. pylori infection (Fry et al. 2005) . Among them, endoscopic biopsy for CLO test and histopathologic examination are the most accurate methods (Jang et al. 2015) ; however, these methods are not recommended for children because of their invasiveness. UBT tests are also considered to be a relatively accurate diagnostic method for H. pylori infection but have several limitations, including a high-false positive rate and the possibility of radiation hazards in young children (Mansour-Ghanaei, Sanaei and Joukar 2011; Yang 2016) . Therefore, serological diagnosis of H. pylori infection could be an especially promising approach for diagnosis in children. Cytotoxin-associated gene A protein (CagA), one of the major virulence factors in H. pylori, is translocated into gastric epithelial cells by the type IV secretion system, which can transport effector proteins into target region, and thus interferes with host cell signaling pathways (Jang et al. 2015) . Demonstrating its oncogenic potential, CagA expression was found to induce intestinal carcinogenesis by tumor suppressor gene p53 mutation in a zebrafish model and gastrointestinal carcinomas and hematopoietic malignancies in a transgenic mouse model (Ohnishi et al. 2008; Neal et al. 2013; Hatakeyama 2014) . CagA was originally suggested to be a serodiagnostic antigen in patients with gastric disease (Covacci et al. 1993; Jang et al. 2015) . In addition, cagA is present in ∼70% of H. pylori strains globally; it is found in only 40% of strains from Western countries, whereas 90%-95% of Eastern Asian strains harbor this gene (Jones, Whitmire and Merrell 2010) . Therefore, the presence of CagA-specific antibodies has been investigated for the diagnosis of H. pylori infection in blood samples in countries in Eastern Asia, such as Japan and Korea (Akada et al. 2014) . In this study, we attempted to identify the antigenic determinants of CagA and analyze its diagnostic value for H. pylori infection in children.
MATERIALS AND METHODS

Bacterial strains and serum samples from children
Helicobacter pylori strain #51, which was obtained from a patient with a gastric disorder at the Gyeongsang National University Hospital (GNUH), was grown on Brucella agar (Difco Laboratories, Detroit, MI, USA) containing 10% bovine serum for 3 days at 37
• C under 10% CO 2 and an atmosphere of 100% humidity.
Escherichia coli Rosseta II cells were grown in Luria-Bertani (LB) broth with 1 mM ampicillin for 16 h at 37
Serum samples from 90 patients with gastric disorders, such as abdominal pain and chronic gastritis, and from 220 asymptomatic patients were used in our study, respectively. The serum samples of patients with gastric symptoms were classified into three groups based on their reactivity for the CLO test (strong, moderate or weak). The gastric endoscopic biopsies of the patients were subjected to CLO test according to a procedure described previously (Seo et al. 2014) . Briefly, three gastric antral biopsy samples were collected from the same patient and then incubated in 0.3% urea broth (urea 20 g/L, phenol red 0.04 g/L, KH2PO 4 0.2 g/L and NaCl 0.5 g/L, pH = 6.8). Based on time of the color change of broth, urease activity was examined over 24 h following the grades: no color change, weak (6-24 h), moderate (1-6 h) and strong (<1 h).
Serum samples were kept frozen at -70 • C until use. All serum samples were provided by GNUH, a member of the National Biobank of Korea, after obtaining permission from the hospital ethics committee (GNUHIRB-2016-04-003-001).
PCR amplification of Helicobacter pylori CagA fragments
Total genomic DNA was obtained for gene amplification from H. pylori #51 using a QiaAmp DNA Mini Kit according to the manufacturer's instructions (Qiagen, Hilden, Germany). The sequences of cagA and primers were designed based on published alignments available through GenBank (Table 1) : for cloning, Ned I (TACATG) and BamH I (GGATCC) were included in the N-and C-terminal part of cagA, respectively. CagA fragments were amplified using Taq polymerase (Takara Bio Inc., Otsu Shiga, Japan) following the manufacturer's instructions. Reactions contained 1 μL of genomic DNA template, 5 μL of 10 × PCR buffer (20 mM Mg 2+ ), 5 μL of 10 mM dNTP mixture (2.5 mM each of dATP, dCTP, dGTP and dTTP), 1 μL of external forward primer (10 pmol/μL), 1 μL of external reverse primer (10 pmol/μL), 1 μL of Taq polymerase (5 units/μL) and 36 μL of triple-distilled H 2 O in a total volume of 50 μL. The PCR amplification was performed under the following conditions: 94
• C for 10 min; 35 cycles of 94
• C for 1 min, 55
• C for 1 min and 72
• C for 1 min; and 72
• C for 7 min.
Amplification products were purified using the QIAquick gel extraction kit (Qiagen). Cloning CagA fragments into the pEGexp vector
The PCR products were cloned into the pGEM-T vector. After treatment with restriction enzymes, Ned I and BamH I, with pGEM-T/cagA, the cagA fragments (T1-T19) were obtained followed by gel extraction using the QIAquick gel extraction kit. The cagA fragments were cloned into the pEGexp vector (Fig. 1) . The pEGexp vector was constructed with an N-terminal leader that consists of the amino acid sequence of the GroEL, a chaperonin, based on pET-15b. The pEGexs/cagA (T1-T19) plasmids were transformed into competent E. coli Rosseta II cells for expression. To confirm gene insertion, DNA sequencing was carried out with an ABI 377L automated DNA sequencer (Applied Biosystems, Foster City, USA).
Production of Escherichia coli lysate containing CagA recombinant protein and the recombinant CagA-T6, CagA-T18 and CagA-T19
For expression, LB media cultures (1 L) were inoculated with a 1-mL seed culture of E. coli Rosseta II/pEGexs/cagA clones. When the culture reached an optical density (OD 600 ) of 0.6-0.8, isopropyl β-D-1-thiogalactopyranoside (IPTG; 1 mM) was added, and then the bacteria were cultured continuously for 4 h. The harvested cells were resuspended and lysed by sonication in lysis buffer (50 mM Tris-hydrogen chloride, 100 mM sodium chloride, pH 8.0). Escherichia coli lysates containing CagA recombinant protein were obtained as a supernatant by centrifugation at 5000 × g for 30 min. The recombinant CagA-T6, CagA-T18 and CagA-T19 were purified with nickel-nitrilotriacetic acid (Ni-NTA) chelate affinity chromatography using ProBond Ni-NTA resin (Invitrogen Life Science Technologies, Carlsbad, CA, USA). The bound protein was eluted with elution buffer (50 mM Tris-hydrogen chloride, 100 mM sodium chloride, 160 mM imidazole, pH 8.0). The purified recombinant proteins were stored at -20
• C until use.
Immunoblot analysis of recombinant CagA using Helicobacter pylori-infected human serum samples
Escherichia coli lysate containing CagA recombinant proteins (T1-T17) as well as lysates from cells expressing recombinant CagA-T6, CagA-T18 and CagA-T19 were analyzed by 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) with Coomassie blue staining and transferred to a nitrocellulose membrane. The membrane was immunoblotted with a pooled serum from 300 seropositive patients verified previously (Baik et al. 2004 ) at a 1:500 dilution and an alkaline phosphataseconjugated anti-human IgG (H+L) (Sigma, St. Louis, MO, USA) at a 1:1000 dilution at room temperature for 1 h. Blots were developed with nitro blue tetrazolium (Sigma) and 5-bromo-4-chloro-3-indonyl phosphate (Sigma). The reactivity of immunoblot with positive serum was graded using the Quantity One software (version 4.1, Bio-Rad Hercules, CA, USA).
Development of CagA-T6 enzyme-linked immunosorbent assays
The enzyme-linked immunosorbent assay (ELISA) was performed using 96-well microplates coated with CagA-T6 (10 μg/mL) at 4 • C overnight. Plates were washed with a solution of phosphate-buffered saline containing 0.05% Tween 20 (PBST) after antigen coating and blocked with 3% bovine serum albumin by incubation at 37 • C for 3 h. The plates were incubated with three positive and three negative control serum samples and the patients' serum samples (1:500) at 37
• C for 1 h, followed by incubation with horseradish peroxidase-conjugated goat antihuman IgG (1:10,000; Bethyl Laboratories Inc., Montgomery, TX, USA) at 37
• C for 1 h and washed with PBST. The control serum samples verified in our pervious study were used (Baik et al. 1996) . Color formation occurred using o-phenylene diamine as a substrate and then stopped by the addition of 2 N sulfuric acid. OD was measured at 492 nm using an Emax Precision microplate reader (Molecular Devices, Sunnyvale, CA, USA).
Statistical analysis
The data are expressed as mean ± standard deviation (SD), and statistical significance was analyzed by Student's t-test using the Statistical Package for Social Sciences software (SPSS) version 17.0. Differences were considered significant if a value of P < 0.05 was obtained.
RESULTS
Differential recognition of CagA fragments using pooled human serum samples
The cagA gene was divided into 17 overlapping fragments (T1-T17) of ∼400 bp, and 2 fragments (T18 and T19) of less than 200 bp, which were part of T6 (Fig. 1) . Among the 19 cagA fragments, 18 fragments (with the exception of T14, which failed to be cloned) were cloned into the pEGexp vector. The recombinant CagA proteins (T1-T19) were expressed as fusion proteins with a part of GroEL (771 bp). The molecular masses of the recombinant CagA-T1-CagA-T17 fusion proteins were ∼40 kDa each, as shown in Fig. 2A . Escherichia coli whole cell lysates containing recombinant CagA-T1-CagA-T17 were analyzed by SDS-PAGE and western blotting (Fig. 2) . . The whole cell lysate of E. coli harboring plasmid clones was transferred to a nylon membrane and then subjected to immunoblot analysis. Lanes: 1, CagA-T1; 2, CagA-T2; 3, CagA-T3; 4, CagA-T4; 5, CagA-T5; 6, CagA-T6; 7, CagA-T7; 8, CagA-T8; 9, CagA-T9; 10, CagA-T10; 11, CagA-T11; 12, CagA-T12; 13, CagA-T13; 15, CagA-T15; 16, CagA-T16 and 17, CagA-T17.
The lysates were tested with pooled serum samples from patients with gastric disorders. As shown in Fig. 2C , the CagA-T1-CagA-T17 partial recombinant proteins were reactive with the positive pooled serum samples, but their reactivity varied. The scores for reactivity were divided into four possibilities: nonreactive (0), grade 1 (+), grade 2 (++) and grade 3 (+++). CagA-T6, T10, T12 and T15 showed the strongest reactivity (grade 3), and CagA-T1, T2, T7, T11, T16 and T17 were found to have grade 2 reactivities (Fig. 2) .
Determination of CagA epitopes
The region (1926-2592 bp) that consists of CagA-T6 and CagA-T15 showed the strongest reactivity (grade 3). This region was divided into two fragments (CagA-T18 and CagA-T19) for the analysis of antigenic determinants. As shown in Fig. 3 , CagA-T18 showed higher reactivity with the positive pooled serum samples than CagA-T19, indicating that the former region (CagA-T18, 2050-2247 bp) is an antigenic determinant. CagA-T18 was perfectly the part of CagA-T6; therefore, both CagA-T6 and CagA-T18 were valuable antigens for the diagnosis of Helicobacter pylori infection. CagA-T6 was purified using affinity chromatography and used for development of H. pylori-specific ELISA.
Development of CagA-T6-specific ELISA
ELISA using recombinant CagA-T6 was developed for the diagnosis of H. pylori in children (Fig. 4) . Serum samples were col- lected from a total of 310 children including 90 children with gastric symptoms and 220 children without gastric symptoms. According to the results of CagA-T6-ELISA, the average reactivity of children with gastric symptoms (n = 90) was 1.784 ± 0.5, whereas that of children without gastric symptoms (n = 220) was significantly lower, i.e. 0.573 ± 0.342 (P < 0.01). Ninety children with gastric symptoms were divided into three groups: strong (n = 30, urease test positive within a 1-h reaction time), moderate (n = 30, urease test positive within a 12-h reaction time) or weak/negative (n = 30, urease test weak or negative within a 24-h reaction time) reactivity according to the results of a urease test using endoscopic samples. The average of the strong, moderate, and weak groups was 2.316 ± 0.57, 1.567 ± 0.481 and 1.469 ± 0.451, respectively. The results from the CagA-T6-specific ELISA of the strong group were statistically significant compared to that of the other groups (P < 0.05).
DISCUSSION
CagA, 120-kDa hydrophilic protein, is known to be phosphorylated on its five amino acid (Glu-Pro-Ile-Tyr-Ala, EPIYA) regions (Jones, Whitmire and Merrell 2010) . The genetic size of CagA is mutable for the highly variable EPIYA regions (Shokrzadeh et al. 2010) . The EPIYA regions are highly variable, and CagA-positive strains lead to a higher risk of the development of gastric cancer than the CagA-negative strains (Parsonnet et al. 1997) . Many studies have demonstrated the high antigenicity of CagA for the serodiagnosis of Helicobacter pylori infection. von Wulffen et al. (1988) and Apel et al. (1988) reported that a protein fraction of 120 kDa showed high reactivity against serum samples from H. pylori-infected patients. These results are also consistent with reports from Kaldor et al. (1986) and Hirschl et al. (1988) .
To date, there have been several attempts to use CagA for the study of H. pylori pathogenesis and for the development of methods for the diagnosis of H. pylori infection. Peter et al. produced CagA proteins from H. pylori; however, most researchers produced CagA in an Escherichia coli expression system. CagA production has several challenges, such as its difficulty of purification and size reduction for the production of whole CagA (Cover et al. 1995) . In some experiments, a 230-amino acid (a.a.) long protein fragment of the CagA carboxyl-terminal region was analyzed in the serodiagnosis of H. pylori infection (Xiang et al. 1993 ).
Other partial recombinant CagA proteins (74-1015 and 107-531 a.a.) were also investigated for their effectiveness using the serodiagnostic method (Maeda et al. 1997; Yokota et al. 2000) . The middle region (136-917 a.a.) and, especially, two peptides including CagA epitopes, were identified as the major antigenic region of CagA (Akada et al. 2014) . Even though the potential antigenicity was identified to be the middle region of CagA in a previous study, the sizes of the divided fragments were large-from 771 to 1578 bp (Akada et al. 2014) . Moreover, knowledge of the precise antigenic regions of CagA is required to analyze their antigenicity for use as a serodiagnostic antigen. In this study, CagA was divided into 17 overlapping fragments of ∼400 bp each (T1-T17), which were used for analysis of antigenic determinants. The aim of this study was to produce recombinant CagA-containing epitopes, which can be used for the detection of anti-CagA antibodies in children.
Based on our western blotting results with positive serum samples, CagA-T6, CagA-T10, CagA-T12 and CagA-T15 were the most reactive regions. Among the domains of CagA, the 643-864 a.a. region of CagA (CagA-T6 and CagA-T15) was determined to contain the antigenic determinants. In particular, the 683-749 a.a. region of CagA (CagA-T18) was determined as the most promising epitope of CagA for use as a serodiagnostic antigen. In our study, recombinant CagA-T6 was produced and used for the development of a CagA-T6-specific ELISA. Antibodies from the serum samples of patients in the strong reaction CLO test group showed significantly greater binding activity against the CagA-T6 peptide compared to that of the other groups (P < 0.05). In addition, the reactivities towards the CagA-specific antibodies of patients with gastric symptoms (1.784 ± 0.5) were more than 3-fold higher than that of patients without gastric symptoms (0.573 ± 0.34). However, some patients without gastric symptoms also showed similar IgG reactivity compared to patients with gastric symptoms. Even they did not show gastric symptoms and classified into the patients without gastric symptoms, it was possible that the patients exposed to H. pylori. Most Korean people are likely to be infected with H. pylori during their early childhood. For this reason, it was thought to be considerably challenging to obtain serum samples from people who have never been exposed to H. pylori. Therefore, we could not validate the ELISA using the serum samples from the patients not infected with H. pylori. For the second best, we decided to evaluate the serodiagnostic value of the H. pylori antigen between children with or without gastric symptoms.
Non-invasive, commercial ELISA or western blotting-based methods could be highly useful for the diagnosis of H. pylori infection in children. In this study, recombinant CagA proteins were produced and the epitope regions of CagA were determined. Consequently, partial recombinant CagAcontaining epitopes were evaluated by ELISA for their reactivity against serum samples from children with/without gastric symptoms. Our findings indicate that the partial recombinant CagA may be useful for detecting H. pylori infection in children by improving the test accuracy and minimizing the use of endoscopy.
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